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E-mail address: hinishida@faculty.chiba-u.jp (H. NOver the past decades there has been considerable progress in understanding the multifunctional
roles of mitochondrial ion channels in metabolism, energy transduction, ion transport, signaling,
and cell death. Recent data have suggested that some of these channels function under physiological
condition, and others may be activated in response to pathological insults and play a key role in
cytoprotection. This review outlines our current understanding of the molecular identity and path-
ophysiological roles of the mitochondrial ion channels in the heart with particular emphasis on car-
dioprotection against ischemia/reperfusion injury, and future research on mitochondrial ion
channels.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mitochondria play an important role in energy metabolism
within the cell. In addition, the organelles are also involved in reg-
ulation of cell death and survival, a crucial determinant of apopto-
sis or necrosis. However, the physiological roles of mitochondrial
ion channels on inner membrane are largely unknown. For exam-
ple, K+-selective and/or anion-selective pores are believed to oper-
ate to regulate mitochondrial volume [1], but it is difﬁcult to
achieve in vivo conﬁrmation of this function [2]. Mitochondrial
swelling and shrinkage have been proposed to modulate the rate
of substrate oxidation under normoxic conditions [3] and could
be an important factor in determining the extent of ischemia/
reperfusion injury [4]. At a minimum, energy dissipation due to
channel opening will increase the ﬂux through the electron-trans-
port chain, and if this effect is uncompensated by increased sub-
strate production, then net oxidation of the matrix, as well as achemical Societies. Published by E
m, mitochondrial membrane
nsitive K+ channel; mitoKCa
PTP, mitochondrial perme-
P channel, sarcolemmal ATP-
ion channel; ANT, adenine
armacology, Chiba University
, Chiba 260-8670, Japan. Fax:
ishida).change in reactive oxygen species (ROS) production, will occur.
Thus one potential physiological role of mitochondrial ion channels
may be redox regulation, which is an important intracellular sig-
naling mechanism inﬂuencing transcription, translation, phos-
phorylation cascade, and cell death.
In the cardiovascular systemmitochondria are target organelles
of ischemic insults as well as effectors for cardioprotection. As
pointed out by Jennings and Ganote 30 years ago [5], the heart is
strictly aerobic and consequently vulnerable to a decrease in oxy-
gen supply. Therefore, myocardial ischemia causes immediate and
deep mitochondrial derangements. These include cessation of ATP
synthesis, inhibition of respiration, and depolarization of mito-
chondrial membrane (DWm). This is accompanied by cellular
changes, especially an increase in Ca2+ and phosphate during ische-
mia, and large increases in ROS originating from the respiratory
chain during reperfusion [6]. Also from the therapeutic perspec-
tive, with reference to ischemia/reperfusion injury in the heart
and brain, it is important to note that mitochondrial ion channels
especially play a key role. An increase in mitochondrial K+ ﬂux,
for example, in hearts treated with K+ channel opener compounds
activating mitochondrial ATP-sensitive K+ (mitoKATP) or Ca2+-acti-
vated K+ channels (mitoKCa), has been found to signiﬁcantly de-
crease infarct size and improve functional recovery after
ischemia/reperfusion. On the other hand, blocking mitochondrial
ion channels such as the mitochondrial permeability transition
pore (mPTP) can prevent the loss of mitochondrial function that
leads to necrotic or apoptotic cell death. Since cardioprotectionlsevier B.V. All rights reserved.
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crease in mPTP opening, it is reasonable to hypothesize that these
two phenomena are part of the same signaling pathway. Indeed,
this connection has been demonstrated in a previous report [7].
In this review we describe our current understanding of the
molecular identity and pharmacological properties of important
four mitochondrial ion channels conferring cardioprotection (see
the property of these ion channels in Table 1).
2. The mitochondrial Ca2+ uniporter
Mitochondrial Ca2+ uptake has been recognized for more than
50 years, yet the protein mediating this essential transport process
has still not been clariﬁed. However, the mitochondrial Ca2+ uni-
porter has perhaps the most well-understood transporter in phys-
iology. The Ca2+ uniporter is a relatively fast mechanism and a
channel, which transports Ca2+, Sr2+, Mn2+, Ba2+, but not Mg2+ with
different selectivity and very low afﬁnity [8]. Because of the low
number of uniporters found per mg protein (around 0.001 nmol/
mg protein reported [9]) and the large value of the estimated Vmax
[1200 nmol Ca2+/(mg min)] the turnover of Ca2+ per site can be
calculated to be about 2  104 Ca2+/(site s) [10], in the range of a
fast gated pore. Studies performed on isolated mitochondria al-
lowed the identiﬁcation of some regulatory molecules acting on
Ca2+ uniporter, in particular the most effective inhibitor is hexava-
lent cation ruthenium red (RuR) [11]. This RuR-sensitive Ca2+ up-
take pathway is the primary route for Ca2+ entry into the
mitochondrial matrix, and there is strong evidence that an increase
in matrix Ca2+ is important for stimulating oxidative phosphoryla-
tion at several sites, including the Ca2+-sensitive dehydrogenases of
the Krebs cycle [11] and one or more sites in the electron-transport
chain [12]. This uniporter is modulated by aliphatic polyamines,
such as spermine and aminoglycosides, and by the adenine nucle-
otides, in the order of effectiveness ATP > ADP > AMP (whereas the
nucleoside adenosine is ineffective) [13] as well as several plant-
derived ﬂavonoids [14]. Recently, an inwardly rectifying, highly
Ca2+ selective, low conductance ion channel that is compatible
with mitochondrial Ca2+ uniporter was recorded in a patch-clamp
study of intact heart mitoplasts [15]. However, the molecular
structure of this channel has not yet been determined despite a
number of attempts to identify Ca2+ uniporter protein over years.
Trenker et al. suggested that the uncoupling proteins UCP2 and
UCP3 were promising candidates for enabling Ca2+ uptake in mito-
chondria since isolated liver mitochondria from UCP2 knockout
mice showed no RuR-sensitive Ca2+ uniporter activity [16]. OnTable 1
Mitochondrial ion channels involved in cardioprotection.
Location Type Conductance (150 mM salt
Inner membrane Ca2+ uniporter 6 pS
Inner membrane ATP-sensitive K+ channel 9.7 pS
Inner membrane Ca2+-activated K+ channel 295 pS
Inner membrane Permeability transition pore 0.3–1.3 nS
ANT, adenine nucleotide translocase.the opposite, in new data submitted by Brookes et al. there was
no effect of UCP2 or UCP3 knockout on either Ca2+ uptake or mem-
brane potential depolarization in mitochondria from liver, skeletal
muscle, heart, or kidney [17].
As described below, the inhibition of Ca2+ inﬂux to matrix
through mitochondrial Ca2+ uniporter by mitochondrial K+ cannel
opening results in decrease of mitochondrial Ca2+ overload. Mito-
chondrial Ca2+ loading is associated with cell injury although the
relative contributions of cytoplasmic vs. mitochondrial Ca2+ over-
load are often difﬁcult to assess individually due to their interde-
pendence, and there is not always a clear correlation between
mitochondrial Ca2+ and survival [18].
3. Mitochondrial K+ channel and cardioprotection
Some 25 years ago Lamping et al. showed that pharmacological
agents capable of opening K+ channels have cardioprotective effect
against ischemia/reperfusion injury [19]. Earlier studies naturally
supposed that the target of these compounds was the sarcolemmal
ATP-sensitive K+ (sarcKATP) channel. However, a new door was
opened in 1991, with the discovery of mitoKATP channels in the li-
ver mitochondrial inner membrane [20]. This ﬁnding was bolstered
by evidence that a variety of K+ channel openers and inhibitors
inﬂuenced mitochondrial function [1,21–23], resulting in the
establishment of a link between the mitoKATP channel and cardio-
protection against ischemia/reperfusion injury in intact hearts [23]
and isolated myocytes [24]. Therefore, the focus has shifted re-
cently to the mitochondria as the primary target of these agents.
3.1. Mechanism of cardioprotection by mitochondrial K+ channel
One of the major physiological features of mitochondria is the
generation of a large transmembrane potential across the mito-
chondrial inner membrane. This is a direct consequence of the bio-
chemical reactions that constitute the respiratory chain. Thus,
substrates supplied to mitochondria such as pyruvate, products
of b-oxidation of fatty acids, and some amino acids enter the TCA
cycle and maintain the reduced state of the NADH/NAD+ and
FADH2/FAD couples. These substances supply electrons to the
respiratory chain, which eventually are transferred to oxygen.
The process also transfers protons across the mitochondrial inner
membrane, generating a proton gradient – a proton motive force
that is largely expressed as DWm usually estimated as 180 mV
negative to the cytosol. The Ca2+ uptake into mitochondria is
driven primarily by this large negative electrical potential of the) Putative role Modulators or inhibitors
Ca2+ uptake Divalent ion
Nucleotides
Ruthenium red
Cytoprotection against ischemic injury ATP
Volume regulation GTP
Apoptosis Mg2+
Ca2+
palmitoyl CoA
Cytoprotection against ischemic injury Ca2+
Volume regulation Change in membrane voltage
Charybdotoxin
Necrosis Cyclosporin A
Apoptosis pH
thiols
Ca2+
Bax
ANT inhibition
H. Nishida et al. / FEBS Letters 584 (2010) 2161–2166 2163matrix [10]. Therefore, partial depolarization of DWm through
opening of mitochondrial K+ channels reduces the driving force
for Ca2+ inﬂux through the Ca2+ uniporter, which results in the pre-
vention of mitochondrial Ca2+ overload during ischemia. Ishida
et al. have reported that in rat cardiomyocytes the selective mito-
KATP channel opener diazoxide depolarizes the mitochondrial
membrane and attenuates the mitochondrial Ca2+ overload exper-
imentally evoked by ouabain [25]. Ouabain, a Na+/K+-ATPase inhib-
itor, impairs Na+ extrusion and consequently prevents Ca2+
extrusion via Na+/Ca2+ exchange. Elevation in cytosolic Ca2+ con-
centration eventually results in the accumulation of mitochondrial
Ca2+. Furthermore, we have recently demonstrated that K+ inﬂux
via mitochondrial K+ channels accelerates electron transfer by
the respiratory chain and leads to net oxidation of mitochondria
if uncompensated by electron donors, and attenuates mitochon-
drial Ca2+ overload with accompanying depolarization of the mito-
chondrial membrane [26].
3.2. Mitochondrial ATP-sensitive K+ channel
In 1991, Inoue et al. [20] reported the identiﬁcation of an ATP-
sensitive K+ channel in the mitochondria. They patch clamped
mitoplasts (mitochondria stripped of their outer membranes) from
rat liver and identiﬁed K+ selective channels, sensitive to inhibition
by ATP, 4-aminopyridine and glibenclamide. The conductance of
these channels was lower than that of ssrcKATP channels (about
10 pS in 100 mM matrix K+ and 33 mM cytosolic K+). Subsequent
studies by several groups have demonstrated that mitoKATP may
be the key player in cardioprotection.
Garlid’s group has used two different approaches to study the
channel. In their ﬁrst approach, a protein fraction was puriﬁed on
DEAE-cellulose columns [21], and an ATP-binding afﬁnity column
[27]. The fraction was reported to contain two major proteins of
55 and 63 kDa in size; the larger protein was reported to bind to
ﬂuorescently labeled glibenclamide [27]. The protein fraction was
then incorporated into liposomes containing a K+-sensitive ﬂuores-
cent marker [21,28]. The emission intensity of this marker in-
creases when K+ binds to it. Thus, the rate of ﬂuorescence
increase can be used to quantify K+ transport into the proteolipo-
somes [28]. In their second approach, they assessed steady state
matrix volume by measuring light scattering at 520 nm in the in-
tact isolated mitochondria [29]. The opening of mitoKATP channel
and inﬂux of K+ result in an increase in the osmotic pressure and
water movement into the mitochondrial matrix, which would lead
to an increase in the mitochondrial matrix volume [1]. Thus,
changes in the matrix volume can be used as an indirect measure
of the mitoKATP channel activity.
Our study group has taken a different approach to assay the
function of mitochondrial K+ channels [24–26,30]. This approach
is based on the autoﬂuorescence of mitochondrial ﬂavoproteins
and NADH, which increases with partial uncoupling generated by
mitoKATP channel activation [31,32]. The advantage of this tech-
nique is that it can be used in intact cells. However, there are also
several limitations with this technique. Since the mitochondrial re-
dox potential is a balance between NADH production and oxida-
tion, it does not represent the overall rate of oxidative
phosphorylation of the cell.
O’Rourke et al. have indicated that pharmacological drugs such
as diazoxide open mitoKATP channel, and 5-hydroxydecanoate has
been used as a blocker of mitoKATP channel [24,32]. MitoKATP chan-
nel openers such as diazoxide, nicorandil, minoxidil and so on have
been shown to be cardioprotective in all species examined [33].
The ability of these agents to open mitoKATP channels in their ther-
apeutic dose range was described in 1996 [1]. Diazoxide was 1000
times more potent in opening of mitoKATP channel than in opening
of sarcKATP channel, making diazoxide a valuable tool to determinewhether cardioprotection was mediated by the activation of sarcK-
ATP or mitoKATP channels.
The molecular structure of sarcKATP channel has been clariﬁed
by cloning of the inwardly rectifying K+ channel subfamily Kir6.0
(Kir6.1, 48-kDa and Kir6.2, 44-kDa) and the receptors for sulfonyl-
ureas (SUR1, 177-kDa, SUR2A, 174-kDa, and SUR2B, 174-kDa) [34].
From a reconstitution study, this channel on cardiomyocytes has
been suggested to comprise SUR2A and Kir6.2 [35]. Our functional
study using Kir6.2-deﬁcient mice has provided direct evidence that
Kir6.2 forms the pore region of cardiac sarcKATP channels [36]. On
the other hand, molecular identiﬁcation of mitoKATP channel has
not been achieved yet. Although the molecular structure of mito-
KATP channel remains unclear, experiments using dominant nega-
tive gene transfer have indicated that neither Kir6.1 nor Kir6.2 is
a functionally important part of the mitoKATP channel in intact
cardiomyocytes [37]. In addition, the mitoKATP channel function,
evaluated by ﬂavoprotein oxidation, was preserved in cardiomyo-
cytes of either Kir6.1-deﬁcient [38] or Kir6.2-deﬁcient mice [39].
However, K+ inﬂux activity has been observed when puriﬁed mito-
chondrial proteins in the molecular weight range of 50–60 kDa
have been reconstituted into proteoliposomes [40], and a 54-kDa
protein was tentatively identiﬁed as a component of mitoKATP
channel [21]. The existence of SUR proteins in cardiac mitochon-
dria is still controversial [22], whilst a protein of about 28 kDa
was labeled by [125I]-glibencamide [41]. Recently, some study
has reported that mitoKATP channel is potentially composed of four
mitochondrial proteins (mitochondrial ATP-binding cassette pro-
tein 1, phosphate carrier, adenine nucleotide translocator, and
ATP synthase) and succinate dehydrogenase, and multiprotein
complex [42].
3.3. Mitochondrial Ca2+-activated K+ channel
The second mitochondrial inner membrane K+ channel identi-
ﬁed in the mitochondrial inner membrane by direct patch-clamp
method of mitoplast was the Ca2+-activated K+ channel having
properties resembling the channel of the surface membrane. Mi-
toKCa channel was detected in mitochondria from human glioma
cells in 1999 [43] and cardiac cell mitochondria in 2002 [44]. Our
previous work has suggested that, in a similar manner to that for
the mitoKATP channel, K+ inﬂux via mitoKCa channels accelerates
electron transfer by the respiratory chain and leads to net oxida-
tion of mitochondria if uncompensated by electron donors, and
attenuates mitochondrial Ca2+ overload with accompanying depo-
larization of DWm [26,30]. Furthermore, previous study in our lab-
oratory has also showed that opening of mitoKCa channels is
modulated by PKA and confers cardioprotection against ische-
mia/reperfusion injury in rabbit heart [26].
NS1619, an opener of the mitoKCa channel has cardioprotective
effect in guinea pig, and protection is blocked by the blocker pax-
illine [44,45]. Our recent study has reported that there was no
cross-talk between mitoKATP and mitoKCa – that is, paxilline
blocked effects of NS1619 but not diazoxide, and 5-hydroxydecan-
oate blocked effects of diazoxide but not NS1619 [26]. Cao et al. ob-
served similar absence of cross-talk in cardioprotection
experiments [45]. These ﬁndings suggest distinct channels with
distinct pharmacology and suggest that these two channels consti-
tute alternative mechanisms for raising matrix K+ and generating
ROS.
Large-conductance Ca2+-activated K+ channels are ubiquitously
expressed in both excitable and non-excitable cells and contribute
to diverse physiological processes. Large-conductance Ca2+-acti-
vated K+ channels are composed of tetrameric sets consisting of a
pore-forming a-subunit and an auxiliary subunit, b-subunit [46].
In contrast to ATP-sensitive K+ channels, the large-conductance
Ca2+-activated K+ channels are not functionally expressed in the
CypD
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ANT
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VDAC
ANT ANT
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Fig. 1. (A) The putative molecular components of mitochondrial permeability transition pore (mPTP) formation. As described in the text, the core components of mPTP have
been thought to be cyclophilin D (CyPD), the adenine nucleotide translocase (ANT) and the voltage-dependent anion channel (VDAC, also known as porin). In addition,
benzodiazepine receptor (BR), creatinekinase (CK), and hexokinase (HK) have been suggested to play a regulatory role although the evidence for this is very modest. (B)
Revised mechanism of mPTP in light of recent ﬁndings in gene-targeted mice. VDAC is no longer part of the model and it appears that an outer membrane component may not
even be necessary for this process. ANT now appears to be more of a regulatory protein, and only CypD remains as an established component. The mitochondrial phosphate
carrier (PiC) has been added to model as a potential candidate for the pore-forming unit. IM, inner mitochondrial membrane, OM, outer mitochondrial membrane.
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suggested that a large-conductance Ca2+-activated K+ channel is
expressed in the mitochondrial inner membrane of ventricular
myocytes and of human glioma cells. Studies of the pharmacolog-
ical and biochemical proﬁles have proposed indeed that mitoKCa
channels belong to the Slo-1 family [43,44]; however, the molecu-
lar components of mitoKCa channels also have not been identiﬁed
as mitoKATP channels. Recent study has shown that large-conduc-
tance Ca2+-activated K+ channel b1 subunit transcripts are ex-
pressed in mammalian cardiac mitochondria [47]. Identiﬁcation
of functional molecules forming mitochondrial K+ channels may
make considerable progress in the search for a new type of cardio-
protective agents.
4. Mitochondrial permeability transition pore
Under normal physiological conditions, the mitochondrial inner
membrane is impermeable to all but a few selectedmetabolites and
ions; this is essential to maintain the membrane potential and pH
gradient that together drive ATP synthesis through oxidative phos-
phorylation. However, under conditions of high matrix Ca2+, espe-
cially when this is accompanied by oxidative stress, high
phosphate and low adenine nucleotide concentrations, a non-spe-
ciﬁc pore opens in the inner mitochondrial membrane known as
the mPTP. The mitochondrial permeability transition, ﬁrst detected
as a large amplitude swelling in response to a variety of effectors
(Ca2+, phosphate, and ROS and so on), has been known from the
1950s [48]. The mPTP is a large-conductance (1 nS) mitochondrial
megachannel that allows the passage of solutes with molecular
weights up to 1.5 kDa non-selectively. Therefore, opening of this
channel has two major consequences. First, it allows unrestricted
proton movement across the inner membrane, causing oxidative
phosphorylation to be uncoupled. Not only does this prevent ATP
synthesis but it also enables the proton-translocating ATPase to re-
verse direction and so actively hydrolyse ATP rather than synthe-
sise it. Under such conditions, intracellular ATP concentrations
rapidly decline, leading to the disruption of ionic and metabolic
homeostasis and activation of degradative enzymes such as phos-
pholipases, nucleases and proteases [49]. Unless pore closure oc-
curs, these changes will cause irreversible damage to the cell.
Secondly, opening of just a single pore in one mitochondrion is
likely to cause its immediate depolarization ofDWm. This will then
activate further pore opening in the same mitochondrion sincemPTP opening of calcium loadedmitochondria is activated by depo-
larization of DWm [50]. Thus mitochondria are either fully open or
closed, and it is the fully open state that leads to the mitochondria
swelling [51]. Opening of the mPTP is promoted by high matrix
Ca2+, inorganic phosphate, ROS, fatty acids, and depolarization in
DWm, which all occur during ischemia/reperfusion. Mg2+, adenine
nucleotides, low pH, and cyclosporine A inhibit mPTP opening.
Based upon biochemical and pharmacological studies, the pore
was proposed to consist of the voltage-dependent anion channel
(VDAC) in the outer membrane, the adenine nucleotide translocase
(ANT) in the inner membrane, plus cyclophilin D (CypD) which
mediates the Ca2+ sensitivity of this channel in the matrix [49].
VDAC, ANT, and CypD interact at membrane contact sites and
reconstitution of this complex in vesicles yields a Ca2+-sensitive
channel reminiscent of the mPTP [52].
Prior to the identiﬁcation of VDAC, researchers assumed that
the outer mitochondrial membrane was permeable to small
metabolites and solutes. In lipid bilayers, VDAC can be gated by
voltage, as implied by its name. Voltage can alter the permeability
of the channel and its selectivity for anions versus cations [53]. The
open state, which occurs at low voltage (10 mV, either positive or
negative), is a high-conductance state that allows transport of
metabolites such as ATP and has weak selectivity for anions over
cations. The closed state, which predominates at higher voltages
(more than 30 mV, either positive or negative), is a low-conduc-
tance state for anions, with very low transport of adenine nucleo-
tides and high permeability for cations.
VDAC has always been considered a key component of the
mPTP. This was based on an original hypothesis by Zoratti et al.
[54,55], who suggested that the electrophysiological properties of
the mPTP were reminiscent of those of the VDAC channel. How-
ever, the recent demonstration that mitochondria from VDAC1
knockout mice possess a normal PTP has questioned this proposal
[56]. Similarly, Baines et al. have reported that Ca2+-induced mPTP
was unaffected in either VDAC1/ or VDAC3/mitochondria [57].
These data indicate that VDAC is not an obligatory member of the
PTP protein complex. Moreover, the PTP was still present in mito-
chondria from livers of mice lacking all three isoforms of ANT [58].
Therefore, with the exception of CypD, conﬁrmation of an obliga-
tory role of these proteins in mPTP is lacking. As an alternative to
this pore-forming unit, He and Lemasters have proposed that the
pore itself is actually formed from any misfolded inner membrane
proteins that would be generated during a toxic stress, and that
K+ K+
ΔΨm↓ ΔΨm↓
Suppression of Ca2+ Overload
Ca2+
MitoKCa ChannelMitoKATP Channel
mPTP
Ca2+ Uniporter
(inhibition) (inhibition)
Cardioprotection
(inhibition)
Fig. 2. Schematic representation of the mechanism of protection mediated by
mitochondrial ion channels. Activation of two protective mitochondrial K+ channels,
mitochondrial ATP-sensitive K+ (mitoKATP) channel andmitochondrial Ca2+-activated
K+ (mitoKCa) channels, depolarizes mitochondrial membrane potential (DWm),
which reduces the driving force for Ca2+ inﬂux throughmitochondrial Ca2+ uniporter,
thereby attenuating the mitochondrial Ca2+ overload. Consequently, prevention of
matrix Ca2+ overload inhibits the opening of mitochondrial permeability transition
pore (mPTP) and protects heart cell death by antiapoptic mechanism.
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such denatured proteins [59]. Recently, mitochondrial phosphate
carrier has been added to model as a potential candidate for the
pore-forming unit of the mPTP (Fig. 1) [60].
There is considerable evidence that the mPTP opens during
ischemia/reperfusion, and it has been linked to cytochrome c re-
lease and the triggering of apoptosis [61]. Grifﬁths et al. reported
that the mPTP does not open during ischemia but is activated upon
reperfusion [62]. Since the mPTP opens when there is signiﬁcant
Ca2+ overload and severe energy depletion, and it mediates loss
of matrix constituents, mPTP activation likely represents an irre-
versible terminal event for the mitochondria. We have postulated
that mitochondrial K+ channel activation is involved in cardiopro-
tection and anti-apoptosis through the inhibition of mPTP.
5. Concluding remarks
Recent years have brought robust advances in our understand-
ing of mitochondrial ion channels and the pivotal role of mitochon-
dria in cardioprotection against ischemia/reperfusion injury. In
addition, novel imaging and patch-clamp techniques are now
being applied to identify and characterize mitochondrial ion chan-
nels and the agents that modulate them.
Four different ion channels on mitochondrial inner or outer
membrane have been reported to contribute to the cytoprotection
in this review article: the mitoKATP channel, the mitoKCa channel,
the mitochondrial Ca2+ uniporter, and the mPTP. Our current out-
standing about the link between mitochondrial ion channels and
cardioprotection against ischemia/reperfusion injury is summa-
rized in Fig. 2. Unfortunately, the molecular identity of these chan-
nels remains unknown yet. In order to truly understand the
mechanisms that mediate mitochondrial-driven cell death, it is ur-
gent that we identify the pore-forming units of these channels. It is
therefore essential that we continue to screen for novel pore can-
didates using a variety of genetic and pharmacological technolo-
gies. The pharmacological and structural proﬁle of these channels
is of paramount importance, since targeting these channels may
provide new therapeutic strategies for ischemic heart disease.
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